IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors

Cytokine

Volumn 61, Issue 3, 2013, Pages 898-905

  Ahmed, Mushtaq ^a   Gaffen, Sarah L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adipocyte; Fat; IL 17; Inflammation; Transcription factor

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 17; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 15; KRUPPEL LIKE FACTOR 2; KRUPPEL LIKE FACTOR 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION REGULATION; PRIORITY JOURNAL; PROMOTER REGION;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; CATTLE; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; ENHANCER ELEMENTS, GENETIC; INTERLEUKIN-17; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; PPAR GAMMA; PROMOTER REGIONS, GENETIC; RECEPTORS, GLUCOCORTICOID;

MUS;

EID: 84875375574     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.12.007     Document Type: Article

References (55)

1. Gaffen S.L. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009, 9:556-567.
2. Stockinger B., Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007, 19:281-286.
3. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010, 10:479-489.
4. Onishi R., Gaffen S.L. IL-17 and its target genes: mechanisms of IL-17 function in disease. Immunology 2010, 129:311-321.
5. Khader S.A., Gaffen S.L., Kolls J.K. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2009, 2:403-411.
6. Eid R.E., Rao D.A., Zhou J., Lo S.F., Ranjbaran H., Gallo A., et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432.
7. Shen F., Ruddy M.J., Plamondon P., Gaffen S.L. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol 2005, 77:388-399.
8. Onishi R., Park S., Hanel W., Maitra A., Gaffen S. The SEFIR is not enough: an extended region downstream of the interleukin-17RA SEFIR domain is required for IL-17-dependent signal transduction. J Biol Chem 2010, 285:32751-32759.
9. Doreau A., Belot A., Bastid J., Riche B., Trescol-Biemont M.C., Ranchin B., et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009, 10:778-785.
10. Gaffen S.L. Recent advances in the IL-17 cytokine family. Curr Opin Immunol 2011, 23:613-619.
11. Huang H., Kim H.J., Chang E.J., Lee Z.H., Hwang S.J., Kim H.M., et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ 2009.
12. Shin J.H., Shin D.W., Noh M. Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes. Biochem Pharmacol 2009, 77:1835-1844.
13. Noh M. Interleukin-17A increases leptin production in human bone marrow mesenchymal stem cells. Biochem Pharmacol 2012, 83:661-670.
14. Goswami J., Hernandez-Santos N., Zuniga L., Gaffen S. A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. Eur J Immunol 2009, 39:2831-2839.
15. Zuniga L.A., Shen W.J., Joyce-Shaikh B., Pyatnova E.A., Richards A.G., Thom C., et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol 2010, 185:6947-6959.
16. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
17. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999, 4:585-595.
18. Freytag S.O., Paielli D.L., Gilbert J.D. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 1994, 8:1654-1663.
19. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006, 7:885-896.
20. Lin F.T., Lane M.D. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 1994, 91:8757-8761.
21. Dang D.T., Pevsner J., Yang V.W. The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol 2000, 32:1103-1121.
22. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001, 188:143-160.
23. Green H., Kehinde O. An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell 1975, 5:19-27.
24. Ding J., Nagai K., Woo J.T. Insulin-dependent adipogenesis in stromal ST2 cells derived from murine bone marrow. Biosci Biotechnol Biochem 2003, 67:314-321.
25. Cao Z., Umek R.M., McKnight S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991, 5:1538-1552.
26. Ruddy M.J., Wong G.C., Liu X.K., Yamamoto H., Kasayama S., Kirkwood K.L., et al. Functional cooperation between interleukin-17 and tumor necrosis factor-a is mediated by CCAAT/enhancer binding protein family members. J Biol Chem 2004, 279:2559-2567.
27. Cortez D.M., Feldman M.D., Mummidi S., Valente A.J., Steffensen B., Vincenti M., et al. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta, NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol 2007, 293:H3356-H3365.
28. Maitra A., Shen F., Hanel W., Mossman K., Tocker J., Swart D., et al. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci, USA 2007, 104:7506-7511.
29. Ruddy M.J., Wong G.C., Liu X.K., Yamamoto H., Kasayama S., Kirkwood K.L., et al. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 2004, 279:2559-2567.
30. Birsoy K., Chen Z., Friedman J. Transcriptional regulation of adipogenesis by KLF4. Cell Metab 2008, 7:339-347.
31. Oishi Y., Manabe I., Tobe K., Tsushima K., Shindo T., Fujiu K., et al. Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab 2005, 1:27-39.
32. Kim J.B., Spiegelman B.M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996, 10:1096-1107.
33. Kim J.B., Wright H.M., Wright M., Spiegelman B.M. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA 1998, 95:4333-4337.
34. Mori T., Sakaue H., Iguchi H., Gomi H., Okada Y., Takashima Y., et al. Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J Biol Chem 2005, 280:12867-12875.
35. Tong Q., Dalgin G., Xu H., Ting C.N., Leiden J.M., Hotamisligil G.S. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 2000, 290:134-138.
36. Cooper C., Henderson A., Artandi S., Avitahl N., Calame K. Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res 1995, 23:4371-4377.
37. Banerjee S.S., Feinberg M.W., Watanabe M., Gray S., Haspel R.L., Denkinger D.J., et al. The Kruppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis. J Biol Chem 2003, 278:2581-2584.
38. Sue N., Jack B.H., Eaton S.A., Pearson R.C., Funnell A.P., Turner J., et al. Targeted disruption of the basic Kruppel-like factor gene (Klf3) reveals a role in adipogenesis. Mol Cell Biol 2008, 28:3967-3978.
39. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
40. Newell-Price J., Bertagna X., Grossman A.B., Nieman L.K. Cushing's syndrome. Lancet 2006, 367:1605-1617.
41. Asada M., Rauch A., Shimizu H., Maruyama H., Miyaki S., Shibamori M., et al. DNA binding-dependent glucocorticoid receptor activity promotes adipogenesis via Kruppel-like factor 15 gene expression. Lab Invest 2011, 91:203-215.
42. Tliba O., Damera G., Banerjee A., Gu S., Baidouri H., Keslacy S., et al. Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am J Respir Cell Mol Biol 2008, 38:463-472.
43. Bhandare R., Damera G., Banerjee A., Flammer J.R., Keslacy S., Rogatsky I., et al. Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am J Respir Cell Mol Biol 2010, 42:9-15.
44. Van Bogaert T., De Bosscher K., Libert C. Crosstalk between TNF and glucocorticoid receptor signaling pathways. Cytokine Growth Factor Rev 2010, 21:275-286.
45. Rajala M.W., Scherer P.E. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003, 144:3765-3773.
46. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919. quiz 920.
47. Ahmed M., Gaffen S.L. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev 2010, 21:449-453.
48. Shen F., Li N., Gade P., Kalvakolanu D.V., Weibley T., Doble B., et al. IL-17 receptor signaling inhibits C/EBP{beta} by sequential phosphorylation of the regulatory 2 domain. Sci Signal 2009, 2:2. ra8.
49. Tang Q.Q., Gronborg M., Huang H., Kim J.W., Otto T.C., Pandey A., et al. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc Natl Acad Sci USA 2005, 102:9766-9771.
50. Rosen E.D., Hsu C.H., Wang X., Sakai S., Freeman M.W., Gonzalez F.J., et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 2002, 16:22-26.
51. White U.A., Stephens J.M. Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol 2010, 318:10-14.
52. Vazquez-Tello A., Semlali A., Chakir J., Martin J.G., Leung D.Y., Eidelman D.H., et al. Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy 2010, 40:1312-1322.
53. Sumarac-Dumanovic M., Stevanovic D., Ljubic A., Jorga J., Simic M., Stamenkovic-Pejkovic D., et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 2009, 33:151-156.
54. Pini M., Gove M.E., Sennello J.A., van Baal J.W., Chan L., Fantuzzi G. Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice. Endocrinology 2008, 149:4080-4085.
55. Nagare T., Sakaue H., Matsumoto M., Cao Y., Inagaki K., Sakai M., et al. Over expression of KLF15 transcription factor in adipocytes of mice results in down-regulation of SCD1 protein expression in adipocytes and consequent enhancement of glucose-induced insulin secretion. J Biol Chem 2011, 286:37458-37469.